Likewise, inhibitory nanobodies could be targeted to aquaporin-4 to provide local complement inhibition and ameliorate the complement activating effect of autoantibodies in neuromyelitis optica [130]. This evidence concerns the gene AQP4 and neuromyelitis optica.